Warning: The NCBI web site requires JavaScript to function. more...
Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?
Grabiec AM, Tak PP, Reedquist KA.
Arthritis Res Ther. 2008;10(5):226. Epub 2008 Oct 17. Review.
Related citations
Epigenetic regulation of airway inflammation.
Adcock IM, Tsaprouni L, Bhavsar P, Ito K.
Curr Opin Immunol. 2007 Dec;19(6):694-700. Epub 2007 Aug 27. Review.
The role of histone deacetylases in asthma and allergic diseases.
Bhavsar P, Ahmad T, Adcock IM.
J Allergy Clin Immunol. 2008 Mar;121(3):580-4. Epub 2008 Jan 30. Review.
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue.
Grabiec AM, Krausz S, de Jager W, Burakowski T, Groot D, Sanders ME, Prakken BJ, Maslinski W, Eldering E, Tak PP, Reedquist KA.
J Immunol. 2010 Mar 1;184(5):2718-28. Epub 2010 Jan 25.
Function of histone deacetylase inhibitors in inflammation.
Crit Rev Immunol. 2011;31(3):233-63. Review.
Corticosteroids: the drugs to beat.
Barnes PJ.
Eur J Pharmacol. 2006 Mar 8;533(1-3):2-14. Epub 2006 Jan 24. Review.
Histone deacetylation: an important mechanism in inflammatory lung diseases.
Adcock IM, Ito K, Barnes PJ.
COPD. 2005 Dec;2(4):445-55. Review.
Impact of protein acetylation in inflammatory lung diseases.
Ito K, Charron CE, Adcock IM.
Pharmacol Ther. 2007 Nov;116(2):249-65. Epub 2007 Jul 24. Review.
Histone deacetylase inhibitors in inflammatory disease.
Halili MA, Andrews MR, Sweet MJ, Fairlie DP.
Curr Top Med Chem. 2009;9(3):309-19. Review.
The role of histone deacetylases (HDACs) in human cancer.
Ropero S, Esteller M.
Mol Oncol. 2007 Jun;1(1):19-25. Epub 2007 Mar 7. Review.
Histone acetylation and deacetylation: importance in inflammatory lung diseases.
Barnes PJ, Adcock IM, Ito K.
Eur Respir J. 2005 Mar;25(3):552-63. Review.
Histone deacetylases in RA: epigenetics and epiphenomena.
Grabiec AM, Reedquist KA.
Arthritis Res Ther. 2010;12(5):142. Epub 2010 Oct 11.
Expression and activity of histone deacetylases in human asthmatic airways.
Ito K, Caramori G, Lim S, Oates T, Chung KF, Barnes PJ, Adcock IM.
Am J Respir Crit Care Med. 2002 Aug 1;166(3):392-6.
Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.
Huang L.
J Cell Physiol. 2006 Dec;209(3):611-6. Review.
Regulation of histone deacetylase activities.
Sengupta N, Seto E.
J Cell Biochem. 2004 Sep 1;93(1):57-67. Review.
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.
Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ.
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8921-6. Epub 2002 Jun 17.
Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
Mroz RM, Noparlik J, Chyczewska E, Braszko JJ, Holownia A.
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):453-60. Review.
Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis.
Gray SG, Dangond F.
Epigenetics. 2006 Apr-Jun;1(2):67-75. Epub 2006 Mar 5. Review.
Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN, Kim NH, Lee W, Seo DW, Kim YK.
Mol Cancer Res. 2009 May;7(5):735-44. Epub 2009 May 12.
Depletion of histone deacetylase protein: a common consequence of inflammatory cytokine signaling?
Gopal YN, Van Dyke MW.
Cell Cycle. 2006 Dec;5(23):2738-43. Epub 2006 Dec 1.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on